CDST_LT: Comorbidity screening and testing TB Co-morbidities & Special Situations HIV in TB Patients Diabetes among people with TB TB in Pregnant and Lactating Women COVID-19 in TB patients
CDST_LT: Public health actions for TB Public Health Actions Contact Tracing and Investigation Direct Benefit Transfer [DBT] under NTEP Various Direct Benefit Transfer Schemes Linkages to Social Welfare Schemes
CDST_LT: TB preventive therapy TB Preventive Therapy Eligibility for TPT Testing for TB Infection Regimen for TPT
CDST_LT: TB treatment initiation and Followup TB Treatment Initiation Follow-up of TB patient TB Treatment Outcome Adverse Drug Reactions [ADRs] Long Term Post-treatment follow up of TB patients Universal Drug Susceptibility Testing [UDST] Screening and diagnosis for DRTB
CDST_LT: General concepts in TB treatment First line anti TB drugs TB Drug Regimen Treatment Phases FDCs used in NTEP
CDST_LT: Emergency preparedness Emergency Preparedness Plan in TB Lab Settings TB Laboratory Accidents Leading to Infectious Spillage Spill Clean-up Kit in TB Lab Settings Chemical Safety in TB Lab Settings Fire Safety in TB Lab Settings
CDST_LT: Personal Protective Equipment (PPE) Personal Protective Equipment [PPE] Use in TB Lab Settings Use of a PPE in a DMC Laboratory Gowns for Use by Lab Personnel Donning and Doffing of PPE N95 Respirators for TB Lab Personnel Gloves for TB Lab Personnel
CDST_LT: TB laboratory classification Classification of TB Laboratories Low-risk TB Laboratories Moderate-risk TB Laboratories
CDST_LT: Biosafety measures for TB Laboratories TB Laboratory Design and Facilities as a Biosafety Measure Ventilation in TB Laboratories as a Biosafety Measure Biosafety Measures for TB Laboratory Equipment
CDST_LT: Introduction to biosafety Biosafety in TB Laboratories Biosafety in TB Laboratory: Risk Assessment Process Biosafety in TB Laboratory: Risk Monitoring Biosafety in TB Laboratory: Factors to be Considered in TB Laboratory Risk Assessment
